{"id":"https://openalex.org/W2003674912","doi":"https://doi.org/10.1007/bf02253531","title":"Involvement of \u03b4-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice","display_name":"Involvement of \u03b4-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice","publication_year":1993,"publication_date":"1993-07-01","ids":{"openalex":"https://openalex.org/W2003674912","doi":"https://doi.org/10.1007/bf02253531","mag":"2003674912","pmid":"https://pubmed.ncbi.nlm.nih.gov/7870983"},"language":"en","primary_location":{"id":"doi:10.1007/bf02253531","doi":"https://doi.org/10.1007/bf02253531","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02253531","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111580437","display_name":"Minoru Narita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Minoru Narita","raw_affiliation_strings":["Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001653266","display_name":"Tsutomu Suzuki","orcid":"https://orcid.org/0000-0002-9731-1731","observed_orcids":["https://orcid.org/0000-0002-9731-1731"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsutomu Suzuki","raw_affiliation_strings":["Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, 142, Tokyo, Japan","Department of Pharmacology, School of Pharmacy , Hoshi University , Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, 142, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]},{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy , Hoshi University , Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068228068","display_name":"Masahiko Funada","orcid":"https://orcid.org/0000-0003-1330-7522","observed_orcids":["https://orcid.org/0000-0003-1330-7522"]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiko Funada","raw_affiliation_strings":["Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, 142, Tokyo, Japan","Department of Pharmacology, School of Pharmacy , Hoshi University , Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, 142, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]},{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy , Hoshi University , Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072308083","display_name":"Miwa Misawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36296616","display_name":"Hoshi University","ror":"https://ror.org/01mrvbd33","country_code":"JP","type":"education","lineage":["https://openalex.org/I36296616"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Miwa Misawa","raw_affiliation_strings":["Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, 142, Tokyo, Japan","Department of Pharmacology, School of Pharmacy , Hoshi University , Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, 142, Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]},{"raw_affiliation_string":"Department of Pharmacology, School of Pharmacy , Hoshi University , Tokyo, Japan","institution_ids":["https://openalex.org/I36296616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109422523","display_name":"Hiroshi Nagase","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115317","display_name":"Toray Industries, Inc. (Japan)","ror":"https://ror.org/029xh1r47","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210115317"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Nagase","raw_affiliation_strings":["Basic Research Laboratories, Toray Industries, Inc., 248, Kamakura, Japan","Basic Research Laboratories, Toray Industries, Inc., Kamakura, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Basic Research Laboratories, Toray Industries, Inc., 248, Kamakura, Japan","institution_ids":["https://openalex.org/I4210115317"]},{"raw_affiliation_string":"Basic Research Laboratories, Toray Industries, Inc., Kamakura, Japan","institution_ids":["https://openalex.org/I4210115317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.0818,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.74680595,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"111","issue":"4","first_page":"423","last_page":"426"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.6151999831199646,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.6151999831199646,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.3707999885082245,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/delta-opioid-receptor","display_name":"delta opioid receptor","score":0.9909999966621399},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.996999979019165},{"id":"https://openalex.org/keywords/naltrindole","display_name":"naltrindole","score":0.8270000219345093},{"id":"https://openalex.org/keywords/naltriben","display_name":"naltriben","score":0.9959999918937683},{"id":"https://openalex.org/keywords/hyperlocomotion","display_name":"hyperlocomotion","score":0.9179999828338623},{"id":"https://openalex.org/keywords/mesolimbic-dopamine-system","display_name":"mesolimbic dopamine system","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dopamine-turnover","display_name":"dopamine turnover","score":0.9710000157356262},{"id":"https://openalex.org/keywords/antinociception","display_name":"antinociception","score":0.9179999828338623},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.5649999976158142},{"id":"https://openalex.org/keywords/limbic-forebrain","display_name":"limbic forebrain","score":0.9549999833106995}],"concepts":[{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.7991522550582886},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6964117884635925},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6363014578819275},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5408336520195007},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5270940065383911},{"id":"https://openalex.org/C2777650357","wikidata":"https://www.wikidata.org/wiki/Q1569460","display_name":"Mesolimbic pathway","level":5,"score":0.5180299878120422},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.44647327065467834},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4310099184513092},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.4179169833660126},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.36227136850357056},{"id":"https://openalex.org/C2780948874","wikidata":"https://www.wikidata.org/wiki/Q640562","display_name":"Ventral tegmental area","level":4,"score":0.34448567032814026},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2850562334060669},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15228122472763062}],"mesh":[{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004856","descriptor_name":"Postural Balance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006719","descriptor_name":"Homovanillic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008032","descriptor_name":"Limbic System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011930","descriptor_name":"Reaction Time","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015102","descriptor_name":"3,4-Dihydroxyphenylacetic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017465","descriptor_name":"Receptors, Opioid, delta","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D017465","descriptor_name":"Receptors, Opioid, delta","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf02253531","doi":"https://doi.org/10.1007/bf02253531","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf02253531","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:7870983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7870983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1484127898","https://openalex.org/W1879282201","https://openalex.org/W1958969306","https://openalex.org/W1964544573","https://openalex.org/W1985718060","https://openalex.org/W2005322655","https://openalex.org/W2006112766","https://openalex.org/W2011645297","https://openalex.org/W2024666284","https://openalex.org/W2026239397","https://openalex.org/W2037271055","https://openalex.org/W2040825227","https://openalex.org/W2043023167","https://openalex.org/W2065716899","https://openalex.org/W2090061296","https://openalex.org/W2273065775","https://openalex.org/W2275009642"],"related_works":["https://openalex.org/W2005660853","https://openalex.org/W2137012042","https://openalex.org/W2011944526","https://openalex.org/W2075320009","https://openalex.org/W2014228793","https://openalex.org/W2282537622","https://openalex.org/W2078682604","https://openalex.org/W2087082140","https://openalex.org/W1929667086","https://openalex.org/W1879282201"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}